Studies
An Open label, Multi-Center, Phase 3 Efficacy of Sub-Q Abatacept (Orencia) in Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis (JIA)
Pediatrics
Immunology
Arthritis
Pediatric Subjects